Clinical Neurophysiology: An Overview


1CHAPTER 1






Clinical Neurophysiology: An Overview


Edward C. Mader, Jr., Daniella Miller, and Piotr W. Olejniczak


CLINICAL NEUROPHYSIOLOGIC TESTING


Clinical neurophysiology (CNP) is a time-honored medical specialty that continues to make great strides, bolstered by rapid advances in neuroscience, biomedical engineering, and computer technology. It encompasses a wide range of methods and techniques for recording, presenting, and analyzing neurophysiologic signals in order to diagnose sensory, motor, autonomic, and central nervous system disorders. Testing performed in CNP or procedures used in current neurological practice include a variety of modality-specific and mixed-modality tests (Table 1.1).


Modality-specific CNP tests are performed to assess specific functional modalities using biomedical instruments that measure changes in neurophysiologic signals that occur spontaneously or with activation. Spontaneous fluctuations in electrical and magnetic fields during brain cortical activity are detected with EEG and magnetoencephalography (MEG) (1,2). Changes in electrical potentials with nerve and muscle activity are measured with electromyography (EMG) and nerve conduction studies (NCSs) (3). Subtle changes in the function of signaling pathways can be detected with evoked potentials (EPs), of which the most clinically useful are somatosensory (SSEPs), brainstem auditory (BAEPs), visual (VEPs), and motor (MEPs) evoked potentials (4). SSEPs are elicited by electrical stimulation of the median nerve (M-SSEP), the tibial nerve (T-SSEP), and rarely from other peripheral nerves. MEPs are activated by means of transcranial electrical stimulation (TES-MEP) or transcranial magnetic stimulation (TMS-MEP). The brain’s ability to anticipate or respond to cognitive events is examined using event-related potentials (ERPs), such as the Bereitschaftspotential (BSP), contingent negative variation (CNV), P300 (P3), and mismatch negativity (MN) (5). CNP autonomic function testing includes measurement of heart rate variability with deep breathing (HR-DB), recording of blood pressure (BP) and heart rate (HR), response to head-up tilt (HUT) and Valsalva (VAL) maneuver, and sudomotor function by means of the quantitative sudomotor axon reflex test (QSART) and the thermoregulatory sweat test (TST) (6).


Mixedmodality (aka multi-modality) CNP tests utilize two or more test modalities to assess complex states (e.g., sleep, coma), to track multiple physiologic parameters, or to obtain more accurate results. During sleep studies, scalp EEG, chin EMG, and EOG (electrooculogram) allow tracking of sleep–wake stages; additional physiologic processes, such as nasal airflow, ventilatory effort, snoring, blood oxygen saturation, ECG, and anterior tibialis EMG, are recorded during polysomnography (PSG) (7). As a rule, neurophysiologic intraoperative monitoring (NIOM) is unimodal with the test modality chosen based on the structures at risk during the procedure, but multimodal NIOM may be superior for selected surgical procedures, such as combining SSEP and MEP monitoring during surgery on the spine (8). In multimodal neuromonitoring (MNM), cerebral blood flow, brain tissue oxygenation, and brain tissue metabolism are monitored, in addition to intracranial pressure (ICP) and EEG, to improve outcome in acute brain injury (9). The multimodal approach, known as coregistration, involves superimposing the data of two or more test modalities to achieve a level of accuracy that is not attainable if each modality is analyzed separately (10). Examples of coregistration techniques are electric source imaging (ESI), magnetic source imaging (MSI), and combined electric-magnetic source imaging (EMSI).


Specific test methods or protocols are selected based on test objectives, patient characteristics, clinical setting, and other factors (11–14). While the routine approach is sufficient in most cases, some clinical problems and situations require modifications or refinements in the routine method. For example, the following EEG methods and protocols are aimed at different clinical scenarios: routine scalp EEG, extended EEG recording, ambulatory EEG, neonatal EEG, brain death study, ICU-EEG monitoring, IOM-EEG monitoring, long-term monitoring (LTM) of video and EEG in the epilepsy monitoring unit (EMU), electrocorticography (ECoG), stereo-EEG, and coregistration techniques, such as ESI and EMSI. It may be prudent to combine different test modalities to obtain more accurate results, such as simultaneous EEG and EMG recording to better define the seizure type and EEG recording during HUT to distinguish postsyncopal convulsions from epileptic seizures and psychogenic events.


2TABLE 1.1: Clinical Neurophysiologic Tests in Current neurological Practice


































EEG


     Routine scalp EEG (adult/pediatric/neonatal)


     Ambulatory scalp EEG monitoring


     Electrocorticography


     Stereo-electroencephalography


     Epilepsy monitoring unit EEG


     ICU-EEG monitoring


     Intraoperative EEG monitoring


Cortical electrical potential (EEG)


EEG recorded on the scalp


EEG recorded with subdural electrodes


EEG recorded with depth electrodes


EEG recorded on the scalp or intracranially


Same as scalp EEG


Same as scalp EEG


MEG


     Spontaneous MEG


     Evoked MEG


Cortical magnetic flux density (MEG)


Cortical magnetic flux density (MEG)


EMG


     Needle EMG


     Single-fiber EMG


     Surface EMG


Motor unit action potential


Single-muscle-fiber action potential


Myogenic electrical potential (surface EMG)


NCS


     Sensory nerve conduction studies


     Motor nerve conduction studies


     Including repetitive stimulation and F-wave studies


     Sensory–motor reflex studies including H reflex, blink reflex, and LLR studies


     Intraoperative CMAP monitoring


Sensory nerve action potential


CMAP: M wave


CMAP: M wave, F wave


CMAP: H wave


CMAP: R1 and R2 responses, LLR response


Same as M-NCS


EP studies


     Pattern-shift VEPs


     Flash VEPs FVEPs


     BAEPs


     SSEP via median/tibial nerve stimulation


     MEP via transcranial electric/magnetic stimulation


     Intraoperative MEP monitoring


     Intraoperative SSEP monitoring


     Intraoperative BAEP monitoring


     Intraoperative FVEP monitoring


Cortical electrical potential (P100, N100)


Electrical potentials I, II, III, IV, V, VI


Auditory nerve (I), brainstem (II–V) potential


Peripheral nerve (N9/N8), cord (N13/N22),


subcortical (P14, N18/P31, N34), cortical (N20/P37)


Direct wave, indirect waves, and


CMAP: M wave


Same as MEP


Same as M-SSEP/T-SSEP


Same as BAEP


Same as FVEP


Event-related potential studies


     Readiness or BSP


     CNV


     Oddball paradigm


     MN


3Cortical electrical potential (BSP or premotor potential)


Cortical electrical potential (CNV)


Cortical electrical potential (P300 or P3)


Cortical electrical potential (MN)


Autonomic function tests


     HR variability with deep breathing


     Head-up tilt or tilt table test


     Valsalva maneuver


     Quantitative sudomotor axon reflex test


     Thermoregulatory sweat test


Cardiac electric potential (ECG)


BP, HR


BP, HR


Sweat volume


Sweat distribution


Polygraphic sleep studies


     PSG


     Multiple sleep latency test


     Maintenance of wakefulness test


Sleep stage: scalp EEG, chin EMG, and EOG


Other parameters (PSG): respiratory airflow and effort, blood oxygenation, ECG, tibialis anterior EMG, etc.


Multimodal neuromonitoring


     Multimodal intensive care neuromonitoring


     Multimodal intraoperative neuromonitoring


Intracranial pressure, brain perfusion, oxygenation, etc.


Two or more types of signal or test parameters


Multimodal coregistration


Electric source imaging


Magnetic source imaging


Electric and magnetic source imaging


EEG coregistered with brain neuroimage


MEG coregistered with brain neuroimage


EEG and MEG coregistered with brain neuroimage


Note: The first seven categories comprise modality-specific tests, and the last three categories consist of mixed-modality tests (see text for explanation). Listed under each test category are test methods or protocols aimed at specific clinical settings and test objectives. The right column shows the signal of interest or physiologic parameter(s) recorded during neurophysiologic testing.


BAEP, brainstem auditory evoked potential; BP, blood pressure; BSP, Bereitschaftspotential; CMAP, compound motor action potential; CNV, contingent negative variation; EMG, electromyography; EOG, electrooculogram; EP, evoked potential; FVEP, flash visual evoked potential; HR, heart rate; LLR, long-latency reflex; MEG, magnetoencephalography; MEP, motor evoked potential; MN, mismatch negativity; M-NCS, motor nerve conduction study; M-SSEP, median nerve somatosensory evoked potentials; NCS, nerve conduction study; PSG, polysomnography; SSEP, somatosensory evoked potentials; T-SSEP, tibial nerve somatosensory evoked potentials; VEP, visual evoked potentials.


4CNP tests measure specific biosignals or physiological parameters (Table 1.1) allowing clinicians to probe and assess selected facets of the patient’s functional anatomy (Table 1.2). The biosignals or physiological parameters recorded reflect the function of specific anatomical structures (Table 1.3). Based on recorded signal characteristics (Figures 1.2 and 1.3), the clinical neurophysiologist can tell if anatomical structures, circuits, or pathways are functioning normally or are affected by pathological processes (Tables 1.4 and 1.5).


Brain function is reflected in the EEG, MEG, ERP, and EP cortical and subcortical components (1,2,6,8). Even when EEG and MEG signals arise from the same cellular processes in the cerebral cortex, there are differences in the way EEG and MEG data are recorded and interpreted (15). A reference is required to record EEG, but not MEG. Because the skull and scalp do not distort magnetic fields as much as electrical fields, the spatial resolution of MEG is superior to EEG (1,2). EEG can detect activity in “more” brain areas by recording radial dipoles, but MEG is more sensitive to tangential dipolar activity in the superficial cortical sulci, making it superior for source localization; for example, MEG is used for MSI and more precise localization of the epileptogenic focus (2). While EEG is widely used in clinical practice, MEG is available only in far fewer centers. The constant interaction between cortical and subcortical structures implies that diencephalic-brainstem disturbances will also affect the EEG/MEG. Assessment of modality-specific brain structures is performed with VEP, BAEP, SSEP, LLR, ERP, and other CNP tests (see later) (3–6). Brain function assessment is the goal of IOM-EEG, sleep studies, and MNM of cerebral perfusion, oxygenation, and metabolism (1,7–9).


Muscle, peripheral nerve, and lower motor neuron function is routinely tested with needle EMG and NCS (3,16). During needle EMG, motor unit action potential (MUAP) number and firing rate increase with the force of muscle contraction. Each MUAP represents activation of a motor unit (i.e., one motor neuron, its nerve fiber, and all muscle fibers innervated by branches of the same nerve fiber). NCS is performed to assess signal conduction along fast-conducting large-diameter nerve fibers: S-NCS for sensory and M-NCS for motor nerve fibers. Neuromuscular junction transmission is evaluated by repetitive nerve stimulation and single-fiber EMG (3,16). F-wave recording extends the utility of M-NCS for evaluating lower motor neurons, motor nerve roots, and proximal motor nerves. These motor structures, along with the sensory nerve roots and central components of reflex pathways, can be evaluated with the H reflex, long-latency reflex, or blink reflex (3,17).


Modality-specific neural pathway or circuit activity is reflected in the EP or ERP signals that are generated when components of the pathway or circuit are activated (4,5,8). The dorsal column pathway is evaluated with M-SSEP and T-SSEP (18), the visual pathway with pattern-shift or flash VEP (19), the auditory pathway with BAEP (20), and the central motor pathway with TES-MEP or TMS-MEP (21). IOM-SSEP and IOM-MEP can be combined if both dorsal and ventral territories of the spinal cord are surgically at risk (22). The neurophysiological substrates of ERP have not yet been identified with certainty. BSP and CNV correlate with movement preparation and motor processing in the frontal lobe, P300 with selective attention and stimulus discrimination in the parietal lobe, and MN with sound feature discrimination, sensory learning, and perceptual accuracy (5,23).


Autonomic regulation of somatic and visceral function by the parasympathetic and sympathetic nervous system is mediated via slow-conducting small-fiber autonomic nerves that innervate most organs and tissues (6,24). Some autonomic function tests are organ specific, such as pupillometry, lacrimation tests, tests of saliva production, gastric motility tests, and urodynamic studies. In CNP, autonomic testing is performed to evaluate parasympathetic cardiovagal reflexes (HR-DB and VAL), sympathetic vasomotor reflexes (VAL and HUT), and sympathetic sudomotor function (QSART and TST). QSART evaluates the sympathetic axon reflex and TST evaluates the integrity of the sympathetic thermoregulatory pathway from the hypothalamus to eccrine sweat glands (6,24).


The sensitivity of CNP tests is remarkable and most tests will show abnormal results before the onset of clinical signs and symptoms. Unfortunately, CNP tests are also sensitive to technical factors and to noise. Exceptional care should therefore be exercised always to avoid overinterpreting neurophysiologic data. The specificity of CNP tests is limited to the identification of physiological disturbances or disorders in functional anatomy. To reach an etiologic diagnosis, neurophysiological data should always be interpreted in the context of the clinical history, physical examination, and other laboratory test results.


5TABLE 1.2: Classification of Clinical Neurophysiologic Tests Based on Functional Anatomy or Neural Pathway Tested












Tests of global/focal cortical, diencephalic, and/or brainstem function


     EEG—spontaneous, scalp-based cortical activity, including influence of diencephalic and brainstem structures


     ECoG—focal/regional brain activity, including influence of diencephalic and brainstem structures


     Stereo-EEG—focal limbic or deep-brain activity influenced by other cortical and noncortical structures


     Epilepsy monitoring unit EEG—same as EEG, ECoG, or stereo-EEG


     ICU-EEG—same as EEG


     IOM-EEG—same as EEG


     MEG—same as EEG, but superior for detecting localized cortical activity


     MNM—global cerebral perfusion, oxygenation, metabolism, neocortical activity (see EEG)


     Sleep studies—same as EEG, with emphasis on the function of the brain’s sleep and wake centers


Tests of muscle, peripheral nerve, motor neuron, and/or reflex function


     Needle EMG—motor units activated by volition, spontaneous activity of muscle fibers/motor units


     Single-fiber EMG—neuromuscular junction and muscle fiber activity


     Surface EMG—multiple motor units activated spontaneously or volitionally


     S-NCS—large-fiber sensory peripheral nerve fibers


     M-NCS—large-fiber motor peripheral nerve fibers, neuromuscular junction, and muscle fibers


     Repetitive stimulation—same as motor NCS, with emphasis on neuromuscular junction transmission


     F-wave study—large-fiber motor peripheral nerve fibers, muscle fibers, multiple motor units


     IOM-CMAP—same as motor NCS


     H reflex—large-fiber peripheral sensory nerve fibers and multiple motor units (H wave)


     Long-latency reflex—large-fiber sensory pathway, somatomotor cortex, corticospinal tract, multiple motor units


     Blink reflex—trigeminal nerve V1 branch, nuclei and tracts in pons and medulla, facial nerve, orbicularis oculi fibers


Tests of central sensory/motor pathway and/or focal cortical function


     VEP—QSART, quantitative sudomotor axon reflex testion, visual cortex


     BAEP—auditory pathway: ear, auditory nerve, cochlear nucleus, lateral lemniscus, inferior colliculus


     M-SSEP—somatosensory pathway: median nerve, dorsal column, medial lemniscus, thalamus, somatosensory cortex


     T-SSEP—somatosensory pathway: tibial nerve, dorsal column, medial lemniscus, thalamus, somatosensory cortex


     TES-MEP—motor pathway: motor cortex, corticospinal tract, multiple motor units


     TMS-MEP—motor pathway: motor cortex, corticospinal tract, multiple motor units


     IOM-SSEP—same as M-SSEP/T-SSEP


     IOM-MEP—same as TES-MEP/TMS-MEP


     BSP—frontal lobe premotor cortex circuits involved with movement preparation and execution


     CNV—frontal lobe premotor cortex circuits involved with movement preparation


     P300—parietal lobe circuits for selective attention and stimulus discrimination


     MN—temporal lobe auditory cortex circuits for sound feature discrimination


     ESI, MSI, or EMSI—focal area of cerebral cortex generating signal of interest (e.g., epileptiform discharges)


6Tests of autonomic function


     HR-DB—parasympathetic cardiovagal reflexes


     HR-VAL—parasympathetic cardiovagal pathways


     BP-VAL—sympathetic baroreflex afferent and efferent pathways


     BP-HUT—sympathetic baroreflex afferent and efferent pathways


     QSART—sympathetic postganglionic sudomotor axon reflex


     TST—sympathetic central, preganglionic, postganglionic pathways and eccrine sweat glands


Note: Modality-specific tests assess the function of specific structures or neural circuits and mixed-modality tests assess multiple functional modalities or complex states (see Table 1.1). Physiological function is assessed by measuring signals generated by specific anatomical structures during a brief time interval (routine method) or by tracking how signals change over time (continuous monitoring).


BAEP, brainstem auditory evoked potential; BSP, Bereitschaftspotential; BP-HUT, blood pressure head-up tilt; BP-VAL, blood pressure Valsalva; CMAP, compound motor action potential; CNV, contingent negative variation; ECoG, electrocorticography; EMG, electromyography; EMSI, Electric and magnetic source imaging; ESI, electric source imaging; HR-DB, heart rate variability with deep breathing; HR-VAL, heart rate Valsalva; IOM, intraoperative monitoring; MEP, motor evoked potential; M-NCS, motor nerve conduction studies; NCS, nerve conduction study; MEG, magnetoencephalography; MN, mismatch negativity; MNM, multimodal neuromonitoring; M-SSEP, median nerve somatosensory evoked potential; MSI, magnetic source imaging; QSART, quantitative sudomotor axon reflex test; S-NCS, sensory nerve conduction study; T-SSEP, tibial nerve somatosensory evoked potential; TES-MEP, transcranial electrical stimulation MEP; TMS-MEP, transcranial magnetic stimulation motor evoked potential; TST, thermoregulatory sweat test; VEP, visual evoked potential.


TABLE 1.3: Generators and Sources of Signal and Test Parameters Measured in Clinical Neurophysiology


































































EEG/MEG


     EEG, ECoG


     MEG


Cortical electrical potentiala


Cortical magnetic flux densityb


Cortical pyramidal cell synaptic potential


Cortical pyramidal cell electric currents


EMG/NCS


     Needle EMG


     Single-fiber EMG


     Surface EMG


Motor unit action potential


MFAP


Myogenic electric potential


MFAP


MFAP


MFAP


Sensory NCS


Motor NCS


F waves


H reflex


Long-latency reflex


Blink reflex


Sensory nerve action potential


CMAPc


CMAP: F wavesb


CMAP: H responseb


CMAP: LL responsesb


CMAP: R1 and R2 responses


Nerve fiber action potential


MFAP


MFAP


MFAP


MFAP


MFAP


EP/ERP


7

VEP


Cortical potential (P100, N100)


Cortical pyramidal cell synaptic potential


FVEP


BAEP


Electrical potentials I, II, III, IV, V, VIc


Auditory nerve action potential (I)


Brainstem farfield potential (IIc, III, IV, V)


Nerve fiber and synaptic potentials


Nerve fiber action potential


Brainstem electric potential


M-SSEP


Peripheral nerve potential (N9)


Cervical cord dorsal horn potential (N13)


Subcortical potential (P14, N18)c


Somatosensory cortical potential (N20)


Nerve fiber action potential


Dorsal horn cell synaptic potential


Synaptic/action potential


Cortical pyramidal cell synaptic potential


T-SSEP


Peripheral nerve potential (N8)


Thoracic cord dorsal horn potential (N22)


Subcortical potential (P31, N34)c


Somatosensory cortical potential (P37)


Nerve fiber action potential


Dorsal horn cell synaptic potential


Synaptic/action potential


Cortical pyramidal cell synaptic potential


MEP


Pyramidal tract potential (D wave, I waves)


Compound motor action potential (CMAP)


Nerve fiber action potential


MFAP


ERP


Cortical potential


Cortical pyramidal cell synaptic potential


Autonomic tests


     HR-DB


     HUT/VAL


     QSART/TST


Electrocardiographic potential (ECG)


Arterial BP (mmHg), heart rate (/min)


Eccrine gland output (sweat)


Cardiac MFAP


Not applicable


Not applicable


Sleep studies


8

EEG (scalp)


EMG (chin)


EOG (near eye)


Cortical electric potentiala


Myogenic electric potential


Oculoelectric dipole


Cortical pyramidal cell synaptic potentiala


MFAP


Corneal–retinal potential


Other parametersd


Respiratory airflow


Respiratory effort


Blood oxygenation


Cardioelectric potential (ECG)


Tibialis anterior muscle potential


Not applicable


Not applicable


Not applicable


Cardiac MFAP


MFAP


Neuromonitoring


     Unimodal NIOM


     Multimodal NIOM MNM


Same as EEG, CMAP, MEP, SSEP, etc.


≥2 modalities, e.g., IOM-SSEP and MEP


ICP, brain perfusion, brain tissue oxygenation, cellular metabolism, etc.


Same as modality-specific test


Same as modality-specific test


Not applicable


Not applicable


Coregistration


     ESI


     MSI


     EMSI


Same as EEG + electromagnetic


Same as MEG + electromagnetic


Same as EEG and MEG + electromagnetic


See EEG above


See MEG above


See EEG and MEG above


Note: This table shows (a) CNP test or test modality (left column); (b) the macroscopic generator and signal or physiologic parameter measured by the test (middle column); and, whenever applicable, (c) the microscopic SGU and the microscopic signal or “building block” of the macroscopic signal (right column).


BAEP, brainstem auditory evoked potential; BP, blood pressure; CMAP, compound motor action potential; ECoG, electrocorticography; EMG, electromyography; EMSI, electric-magnetic source imaging; EOG, electrooculogram; EP, evoked potential; ERP, event-related potentials; ESI, electric source imaging; FVEP, flash visual evoked potentials; HR, heart rate; HR-DB, heart rate variability with deep breathing; HUT, head-up tilt; ICP, intracranial pressure; IOM-SSEP, intraoperative somatosensory evoked potentials monitoring; MEG, magnetoencephalography; MEP, motor evoked potential; MFAP, muscle fiber action potential; MNM, multimodal neuromonitoring; MSI, magnetic source imaging; M-SSEP, median nerve somatosensory evoked potentials; NCS, nerve conduction study; NIOM, neurophysiologic intraoperative monitoring; QSART, quantitative sudomotor axon reflex test; SGU, signal-generating unit; SSEP, somatosensory evoked potentials; TST, thermoregulatory sweat test; T-SSEP, tibial nerve somatosensory evoked potentials; VAL, Valsalva; VEP, visual evoked potentials.


aNonsynaptic and nonneuronal mechanisms may also play a role in EEG/MEG generation.


bLate responses are CMAPs that occur after the classic CMAP known as M wave.


cGenerator(s) of FVEP waves I–VI, BAEP wave II, and SSEP subcortical components remain controversial.


dPhysiologic parameters recorded during PSG in addition to EEG, EOG, and chin EMG (list is incomplete).


Translating bioelectric and biomagnetic signals into physiological information requires a priori knowledge of where and how signals are generated (discussed earlier) and how signals spread from the generator to the recording site. Once generated, bioelectric and biomagnetic fields propagate from the generator to other parts of the body. This mechanism of signal propagation, known as volume conduction, must be distinguished from another mechanism of signal propagation, known as neural transmission. These two mechanisms of signal propagation in biological tissue are quite distinct and result in waveforms with different spatiotemporal characteristics (Figure 1.4).


9TABLE 1.4: Spatiotemporal Characteristics of Bioelectric Signals Measured in Clinical Neurophysiology












































EEG


Cortical electric potentiala


Stationary nearfield


MEG


Cortical magnetic flux densitya


Stationary nearfield


Needle EMG


Single-fiber EMG


Motor unit action potential


MFAPb


Traveling nearfield


Traveling nearfield


Sensory NCS


Motor NCS


Reflexes: H, LL, and blink


Sensory nerve action potential


CMAPc


CMAPc


Traveling nearfield


Traveling nearfield


Traveling nearfield


Pattern-shift VEP


Cortical potential (P100, N100)


Stationary nearfield


BAEP


Auditory nerve action potential (I)


Brainstem farfield potential (IIc, III, IV, V)


Traveling nearfield


Stationary farfield


M-SSEP/T-SSEP


Peripheral nerve action potential (N9/N8)


Cervical cord dorsal horn potential (N13/N22)


Subcortical potential (P14, N18/P31, N34)d


Somatosensory cortical potential (N20/P37)


Traveling nearfield


Stationary nearfield


Stationary farfield


Stationary nearfield


TES-MEP/TMS-MEP


Corticospinal tract action potential (D wave, I waves)


CMAP


Traveling nearfield


Traveling nearfield


ERP


Cortical electric potential


Stationary nearfield


ECGe


Cardiac electric potential


Stationary farfieldd


aNonsynaptic and non-neuronal mechanisms may play a role in the generation of EEG, MEG, ERPs, and cortical EPs


bThe micro/macro stereotype is not applicable since the microscopic signal (MFAP) is also the signal that is recorded.


cLate responses (F waves, H reflex, LL response, R1/R2 responses) are CMAPs that occur after the classic CMAP or M wave.


dNo definite consensus on the generator(s) of BAEP wave II and SSEP subcortical components and of FVEP waves I-VI


eECG is a traveling nearfield signal near its generator but behaves as a farfield stationary signal when recorded in CNP.


Note: For each CNP test or test modality (left column), the macroscopic signal recorded (middle column) and the spatiotemporal characteristics of the recorded signal (right column) are shown.


BAEP, brainstem auditory evoked potential; CMAP, compound motor action potential; EMG, electromyography; ERP, event-related potentials; MEG, magnetoencephalography; MFAP, muscle fiber action potential; M-SSEP, median nerve somatosensory evoked potentials; NCS, nerve conduction study; TES-MEP, transcranial electrical stimulation motor evoked potential; TMS-MEP, transcranial magnetic stimulation motor evoked potential; T-SSEP, tibial nerve somatosensory evoked potentials; VEP, visual evoked potentials.


10TABLE 1.5: Classification of Electrophysiologic Abnormalitiesa




























Signal amplitude


Abnormally low amplitude


     Loss of SGUs—e.g., low SNAP with loss of nerve fibers, EEG attenuation with loss of pyramidal cells


     Decrease in number of SGUs activated—e.g., low CMAP amplitude with loss of nerve fibers


     SGU asynchrony—e.g., low CMAP amplitude due to temporal dispersion of signals in motor nerve fibers


     Changes in volume conductor—e.g., edema increasing distance between generator and electrode


Abnormally high amplitude


     Increase in number of SGUs activated—e.g., giant MUAP with muscle reinnervation of fibers


     Pathologic hypersynchrony of SGUs—e.g., high-amplitude epileptiform waves, giant N20 or P100


     Decrease in impedance of conducting medium—e.g., accentuation of fast EEG waveforms with skull defects


Signal conduction time


Abnormally long latency


     Conduction slowing in peripheral nerve—e.g., prolonged SNAP, CMAP, SSEP, or P100 absolute latency


     Conduction slowing in central tract—e.g., increase in BAEP III-V and SSEP N13-N20 interpeak latencies, temporal dispersion and asynchronous activation of SGUs—usually only mild prolongation in latency


Abnormally short latency


     Not easy to account for with pathology; a technical reason must be excluded—e.g., electrode placement or artifact


Wave morphology or configuration


Abnormal wave morphology


     Combination of abnormalities—e.g., wave amplitude, duration, contour, number of phases/turns


Increase in wave duration and number of phases


     SGU desynchrony—e.g., long CMAP duration due to temporal dispersion of signals in motor nerve fibers


Short wave duration and sharp contour


     SGU hypersynchrony—e.g., EEG and MEG epileptiform discharges, spikes, and sharp waves


11Wave activation, modulation, and repetition


Abnormal activation or recruitment


     Reduced SGU activation—e.g., decreased MUAP recruitment with motor neuron or nerve fiber pathology


     Increased SGU activation—e.g., increased MUAP recruitment due to muscle fiber pathology


     Reduced and increased SGU activation—e.g., release of latent slow rhythms with loss of pyramidal cell input


Abnormal spontaneous activity


     Hyperexcitability of SGUs—e.g., fibrillation potentials, positive sharp waves, complex repetitive discharge


     Hyperexcitability of non-SGU circuit components—e.g., fasciculation potentials, myokymia


     Hyperexcitability of circuit—e.g., EEG or MEG epileptiform activity


Abnormal repetition rate


     Perturbation in network dynamics—e.g., disorganization of EEG or MEG rhythms with encephalopathy


Spatial characteristics


Abnormal spatial distribution


     Often due to the same factors affecting the time-domain characteristics of waves


Apparent displacement of signal generator


     Technical factors—e.g., improper electrode placement


     State change—e.g., drowsiness can manifest as “anterior displacement” of EEG alpha rhythm.


Clinical and physiological context


Physiological state


     Often due to the same factors affecting the time-domain characteristics of waves


Age or developmental period


     Maturational—e.g., dysmature features in the neonatal EEG


aWhen the above framework is used to classify abnormalities in the “raw” MEG record, one must be aware of its limits; for example, magnetic signals are not sensitive to changes in volume conductor properties. The above framework is not suitable for signals that are the product of complex transduction events between the biological source and the signal-sensing probe.


Note: Graphical features, clinical context, and pathophysiology are all taken into consideration in this classification scheme. Macroscopic abnormalities appear in the record as aberrations in amplitude, latency, or configuration of otherwise physiological waves, as a change in activation, modulation, or repetition pattern of physiologically recurring waves, as distortion of the spatial characteristics of waves, or as normally appearing but out-of-context waves in terms of physiologic state or age. Each of these abnormalities occurs because of impairment in SGU or non-SGU circuit components or because of changes in the properties of the volume conductor.


BAEP, brainstem auditory evoked potential; CMAP, compound motor action potential; MEG, magnetoencephalography; MUAP, motor unit action potential; SGU, signal-generating unit; SNAP, sensory nerve action potential; SSEP, somatosensory evoked potentials.


12SIGNAL RECORDING AND GRAPHICAL DISPLAY


The signal that must be recorded and analyzed, or the “signal of interest,” is often simply called “signal.” Any other signal contaminating and potentially distorting the signal of interest is considered “noise.” Noise entering the recording system may appear on the record as artifact. Because signal and noise are physically similar (both are electromagnetic signals), neurophysiologic instruments are intricately engineered to maximize the signal-to-noise ratio during signal recording and processing (25). Moreover, CNP technologists and specialists are trained to distinguish signal from artifact by visual inspection and, if necessary, digital reformation of the record. Chapter 2 is dedicated to instrumentation and signal processing. In this chapter, it is sufficient to mention that neurophysiological recording involves four processes: analog signal acquisition, analog signal conditioning, analog-to-digital conversion, and digital signal processing (Figure 1.1).


Signal analysis and interpretation is performed by professionals trained in CNP. Neurophysiologic data are usually presented and analyzed in the time domain (Figure 1.2). Recorded signals are displayed as waveforms on a computer or oscilloscopic screen (paper recording is nearly obsolete and is omitted from our discussion). CNP records contain one or more lines of tracing, called channels. Each channel is a graph of signal amplitude versus time, with waves rising above and falling below the baseline, indicating fluctuations in signal amplitude with time. When differential amplification is employed in biopotential recording, the wave amplitude at any given time is proportional to the voltage difference between the amplifier inputs, G1 and G2, multiplied by the amplification factor or gain (see Chapter 2) (25).


Quantitative analysis of “raw” data can extract additional information that can complement or supplement basic time-domain data. The fast Fourier transform (FFT) converts data in the time domain to an alternative representation of the same data in the frequency domain (26). Decomposing EEG into its frequency components and using compressed spectral array (CSA) to track the changes in amplitude/power of EEG frequency bands is a useful quantitative EEG (qEEG) technique for detecting cerebral ischemia and seizures during ICU-EEG monitoring (11). EEG trending in neonates is commonly performed using amplitude-integrated EEG (aEEG), a qEEG technique that involves filtering, rectification, smoothing, and compression of time-domain data. Quantitative analysis of MUAP, compound motor action potential (CMAP), HR-DB, and other data can also be performed. Although waveform analysis in the time domain is still the bread and butter of the clinical neurophysiologist, rapidly advancing computer technology and machine learning, and the increasing availability of automated algorithms, will inevitably transform the future practice of CNP.


Spontaneously generated signals represent oscillating physiologic processes, appear graphically as sinusoidal waves, and are referred to as rhythmic activity or rhythms (Figure 1.2A) (27). In EEG/MEG, sustained rhythmic activity is considered “background.” Background activity, not individual waves, serves as the framework for time-domain analysis. Additional waves and rhythms may appear spontaneously or with activation and are mixed with, or replace, the background. Both background activity and emergent waves are signals of interest that are analyzed collectively. The most important graphical descriptor of rhythmic activity is frequency, the number of wave repeats per second, which is reported as Hertz (Hz) or cycles per second (cps or c/s). Frequency is described in precise terms (e.g., 60 Hz) or in terms of frequency bands, including EEG/MEG: less than 4 Hz is delta, 4 to less than 8 Hz is theta, 8 to 13 Hz is alpha, and greater than 13 Hz is beta (28). By interpreting a wave as a basic unit of a rhythm, an isolated waveform can be assigned a frequency that is equal to the reciprocal of its duration.



image


FIGURE 1.1: Signal recording in clinical neurophysiology. The analog signal recorded includes the signal of interest and noise. Signal recording involves four general processes: (1) analog signal acquisition, (2) analog signal conditioning, (3) analog-to-digital conversion, and (4) digital signal processing. The end product of the recording process is a graphical representation or record of the signals (see Figure 1.2).

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jan 13, 2020 | Posted by in NEUROLOGY | Comments Off on Clinical Neurophysiology: An Overview

Full access? Get Clinical Tree

Get Clinical Tree app for offline access